Logo of Huzzle

Home

Matches

Explore

Manage

Co-op Student, Protein Engineering

image

Zymeworks Inc.

2mo ago

Applications are closed

  • Internship
    Full-time
    Off-cycle Internship
  • Research & Development
    Science
  • Vancouver

Requirements

  • Currently enrolled in an undergraduate program in Biology, Biochemistry, Immunology or related discipline.
  • Available for a co-op term of at least 8-months. Successful completion of at least one relevant co-op term is preferred.
  • Skills and Abilities:
  • Proven interpersonal skills with the ability to work collaboratively as a member of a cross-functional team and maintain effective working relationships
  • Highly organized with good attention to detail
  • Results-oriented
  • Knowledge of protein structure is an asset
  • Experience with biophysical characterization methods are an asset
  • Excellent oral and written communication skills, both one-on-one and in a group setting
  • Good computer skills

Responsibilities

  • Assists with the purification of recombinant proteins using a variety of chromatography techniques including affinity and size-exclusion
  • Assists with the characterization of recombinant proteins using a variety of techniques including SDS-PAGE, CE-SDS, western blotting, UV-VIS spectrophotometry, BLI quantitation and UPLC-SEC
  • Evaluate developability of antibody-based molecules
  • Prepares media, buffers and reagents
  • Maintains accurate records of methods and raw data
  • Evaluates data and summarize results for presentations
  • Conducts all activities in accordance with scientific standards, OS&H regulations and established Zymeworks’ policies and practices
  • Adheres to Zymeworks’ standard procedures for generating, documenting and archiving data, and maintaining an up-to-date electronic laboratory notebook
  • Contributes to the routine maintenance of the laboratory

Zymeworks Inc.

Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.

Science & Healthcare
Industry
201-500
Employees
2003
Founded Year

Mission & Purpose

Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab, is a novel Azymetric™ HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. Zymeworks’ second product candidate, Zanidatamab Zovodotin (ZW49), is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks’ proprietary ZymeLink™ linker-cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies.